Abbott Laboratories $20 billion notes offering
We advised the joint book-running managers on the offering
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
Estée Lauder $1.01 billion follow-on offering
The shares are listed on NYSE
S&P Global and CME Group $3.1 billion sale of OSTTRA to KKR
We are advising S&P Global on the transaction
Maze Therapeutics $140 million IPO
The shares are listed on Nasdaq
InVue sale to ASSA ABLOY
We advised InVue on the transaction
Ferrero Group acquisition of Power Crunch
We are advising Ferrero on the transaction
Precigen $34 million follow-on offering
We advised Precigen on the SEC-registered offering
Generation Bio $237 million at-the-market offering
The shares are listed on Nasdaq
WEBTOON Entertainment $315 million IPO
The shares are listed on the Nasdaq Global Select Market
ProKidney $140 million follow-on offerings
We advised ProKidney on the offering